Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Herbert Irving Comprehensive Cancer Center At New York-Presbyterian/Columbia University Medical Center

Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center

Irving Cancer Research Center
1130 St. Nicholas Avenue
2nd Floor, Room 201
New York, New York, United States
Email   Phone   Web  
The Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University is the University’s organizational structure for the conduct of basic, clinical and population-based cancer research and patient care. Patients across the nation and worldwide come to the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center for truly individualized care.
 
Amyloidosis can be difficult to diagnose because its symptoms often mimic those of other conditions. Although it is a very uncommon, it is likely under-diagnosed. Physicians at the Herbert Irving Cancer Center place a high priority on diagnosing and treating patients in the early stage of the disease before organs are seriously affected.
 

Since amyloidosis can affect so many different organs, it is critical to have a multidisciplinary team with specialized experience in all of the different organ systems. At this center, we bring together experts in many different fields to consult with the patient, during a single appointment, thereby minimizing the number of hospital visits needed.

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Suzanne Lentzsch, MD, PhD

Cardiology:
Mathew S. Maurer, MD

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close